1 |
Han AR, Oh JT, Han SJ, Choi SH, Hwang EH. The results of surgical treatment for suppurative cervical lymphadenitis in children. J Korean Surg Soc 2002;62:259-61.
|
2 |
Baek MY, Park KH, We JH, Park SE. Needle aspiration as therapeutic management for suppurative cervical lymphadenitis in children. Korean J Pediatr 2010;53:801-4.
DOI
|
3 |
Gosche JR, Vick L. Acute, subacute, and chronic cervical lymphadenitis in children. Semin Pediatr Surg 2006;15:99-106.
DOI
|
4 |
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33.
DOI
|
5 |
Stamos JK, Corydon K, Donaldson J, Shulman ST. Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994;93:525-8.
|
6 |
Kim JY, Kim JH, Moon SJ, Cho BS, Cha SH. Clinical characteristics of lymphadenopathy as the initial manifestation of Kawasaki disease. Korean J Pediatr Infect Dis 2000;7:152-8.
DOI
|
7 |
Yanagi S, Nomura Y, Masuda K, Koriyama C, Sameshima K, Eguchi T, et al. Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy. Pediatr Int 2008;50:179-83.
DOI
|
8 |
Kanegaye JT, Van Cott E, Tremoulet AH, Salgado A, Shimizu C, Kruk P, et al. Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. J Pediatr 2013;162:1259-63.
DOI
|
9 |
Yun HW, Lee JY, Yang SI, Yu HJ, Kang MJ, Lee SY, et al. Comparison of cervical-lymph-node-first presentation of Kawasaki disease and typical Kawasaki disease. Pediatr Infect Vaccine 2016;23:10-7.
DOI
|
10 |
Kim JO, Kim YH, Hyun MC. Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy. Korean J Pediatr 2016;59:54-8.
DOI
|
11 |
Kim HS, Noh GW, Kim DS, Lee KY, Lee HS, Lee HK, et al. Decreased CD5+ B cells during the acute phase of Kawasaki disease. Yonsei Med J 1996;37:52-8.
DOI
|
12 |
Rowley AH, Shulman ST. Kawasaki syndrome. Clin Microbiol Rev 1988:11;405-14.
|
13 |
Kim KY, Kim DS. Recent advances in Kawasaki disease. Yonsei Med J 2016;57:15-21.
DOI
|
14 |
Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7.
DOI
|
15 |
Ghelani SJ, Sable C, Wiedermann BL, Spurney CF. Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 2012;33:1097-103.
DOI
|